Biologics frequently used in US patients with severe asthma, switching therapies uncommon
Sumary of Biologics frequently used in US patients with severe asthma, switching therapies uncommon:
Moore, MD, professor in the department of pulmonary, critical care, allergy and immunologic diseases at the Wake Forest School of Medicine, Winston-Salem, North Carolina, said during a presentation at the virtual CHEST Annual Meeting..
treated with an FDA-approved monoclonal antibody, receive systemic steroids for 50% or more of the year and/or use high-dose inhaled corticosteroids or other controllers with persistent and uncontrolled disease….
